Company profile
Indigenous Bloom Hemp Corp.
OTC: VRTHF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Kelowna, BCReports USD
#1161 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 36
v0.1 · 5/100 weight · pillars only
↑ listing tenure, disclosure history · ↓ return on assets, balance-sheet leverage
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$1.8M
Employees
—
as of 2026-08-28
Market cap
$131.1k
as of 2026-08-28
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$00 CAD2022
Net income-$1.8M-2.3M CAD2022
Operating income-$331.5k-417.8k CAD2022
Total assets$601.3k760.5k CAD2022
Liabilities$2.5M3.2M CAD2022
Equity-$1.9M-2.4M CAD2022
Revenue trend
FY2017 – FY2022 · USD
FY17
FY18
FY19
FY20
FY21
FY22
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Indigenous Bloom Hemp Corp.’s revenue?
Indigenous Bloom Hemp Corp. booked $0 in FY2022 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Verisante Technology Inc.——Innovation Pharmaceuticals Inc.——TripSitter Clinic Ltd.——DrazCanna, Inc.——GB Sciences, Inc.——Manzo Pharmaceuticals, Inc.57CKey facts
CEOLorne Mark Roseborough
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersKelowna, BC
ExchangeOTC: VRTHF
Employees—
IPO date2016-02-18
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.